Filmed at EuroPCR 2022, Prof Stephan Baldus (University of Köln Medical Center, DE) outlines the first results from a study investigating the use of the JenaValve TAVR device in treating patients with aortic regurgitation.

Discussion Points:

1. Prevalence and burden of aortic regurgitation
2. Treatment options
3. Importance of the technology
4. Considerations and further research

Recorded at EuroPCR 22, Paris.
Interviewer: Jonathan McKenna
Videographer: Oliver Miles
Editor: Jordan Rance